Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC L-Cysteine, L-γ-glutamyl-, 2,2,2-trifluoroacetate (1:1) | 283159-88-6 | 95.2% | 364.30 | 1 ML
SDP

Catalog No. 5000437037
Encompass_Preferred

Gamma-glutamylcysteine TFA (γ-Glutamylcysteine TFA) is an orally active, blood-brain barrier permeable dipeptide. It activates various signaling pathways like AMPK and Nrf2, while inhibiting others such as NF-κB and MAPKs. This compound regulates macrophage polarization, induces glutathione synthesis, improves metabolic dysfunction, and alleviates hepatic lipid droplet formation.

  • Applicable to research related to inflammatory bowel disease.
  • Applicable to research related to type 2 diabetes.
  • Applicable to research related to cadmium-induced neurotoxicity.
  • Applicable to research related to Alzheimer's disease.
  • Applicable to research related to cerebral ischemia/reperfusion injury.
  • Applicable to research related to neuropathy.
  • Applicable to research related to alcoholic liver disease.

Catalog No. 50-004-37037 Supplier Medchemexpress LLC Supplier No. HY113402A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Gamma-glutamylcysteine TFA (γ-Glutamylcysteine TFA) is an orally active, blood-brain barrier permeable dipeptide. It activates various signaling pathways like AMPK and Nrf2, while inhibiting others such as NF-κB and MAPKs. This compound regulates macrophage polarization, induces glutathione synthesis, improves metabolic dysfunction, and alleviates hepatic lipid droplet formation.

  • Applicable to research related to inflammatory bowel disease.
  • Applicable to research related to type 2 diabetes.
  • Applicable to research related to cadmium-induced neurotoxicity.
  • Applicable to research related to Alzheimer's disease.
  • Applicable to research related to cerebral ischemia/reperfusion injury.
  • Applicable to research related to neuropathy.
  • Applicable to research related to alcoholic liver disease.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.